A detailed history of Sargent Bickham Lagudis LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 6,912 shares of TMO stock, worth $4.22 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
6,912
Previous 6,790 1.8%
Holding current value
$4.22 Million
Previous $3.44 Million 10.54%
% of portfolio
0.31%
Previous 0.31%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023

BUY
$484.71 - $571.37 $59,134 - $69,707
122 Added 1.8%
6,912 $0
Q3 2022

Oct 27, 2022

BUY
$507.19 - $604.49 $8,622 - $10,276
17 Added 0.25%
6,790 $3.44 Million
Q2 2022

Jul 13, 2022

SELL
$500.9 - $612.21 $186,334 - $227,742
-372 Reduced 5.21%
6,773 $3.68 Million
Q1 2022

Apr 27, 2022

BUY
$524.0 - $644.92 $223,748 - $275,380
427 Added 6.36%
7,145 $4.22 Million
Q4 2021

Jan 18, 2022

BUY
$569.0 - $667.24 $176,959 - $207,511
311 Added 4.85%
6,718 $4.48 Million
Q3 2021

Nov 05, 2021

BUY
$509.53 - $609.78 $37,195 - $44,513
73 Added 1.15%
6,407 $3.66 Million
Q2 2021

Jul 19, 2021

SELL
$441.0 - $508.24 $86,877 - $100,123
-197 Reduced 3.02%
6,334 $3.2 Million
Q1 2021

May 24, 2021

BUY
$439.85 - $518.83 $210,688 - $248,519
479 Added 7.91%
6,531 $2.98 Million
Q4 2020

May 24, 2021

SELL
$435.06 - $527.66 $208,393 - $252,749
-479 Reduced 7.33%
6,052 $2.82 Million
Q4 2020

May 24, 2021

BUY
$435.06 - $527.66 $347,612 - $421,600
799 Added 13.94%
6,531 $2.98 Million
Q3 2020

Sep 01, 2021

SELL
$359.77 - $441.52 $34,178 - $41,944
-95 Reduced 1.63%
5,732 $2.53 Million
Q2 2020

Sep 07, 2021

BUY
$275.2 - $362.34 $333,267 - $438,793
1,211 Added 26.23%
5,827 $2.11 Million
Q1 2020

Sep 07, 2021

BUY
$255.3 - $340.05 $1.05 Million - $1.41 Million
4,132 Added 853.72%
4,616 $1.31 Million
Q4 2019

Sep 14, 2021

BUY
$271.93 - $328.04 $7,885 - $9,513
29 Added 6.37%
484 $157,000
Q3 2019

Sep 14, 2021

SELL
$268.46 - $305.43 $16,107 - $18,325
-60 Reduced 11.65%
455 $133,000
Q2 2019

Sep 13, 2021

BUY
$257.51 - $295.55 $15,450 - $17,733
60 Added 13.19%
515 $151,000
Q4 2018

Sep 13, 2021

BUY
$208.47 - $251.98 $27,101 - $32,757
130 Added 40.0%
455 $102,000
Q1 2018

Sep 13, 2021

SELL
$192.98 - $224.11 $10,227 - $11,877
-53 Reduced 14.02%
325 $67,000
Q4 2017

Sep 13, 2021

BUY
$182.03 - $200.37 $9,647 - $10,619
53 Added 16.31%
378 $72,000
Q2 2017

Sep 13, 2021

BUY
N/A
25 Added 8.33%
325 $57,000
Q4 2016

Sep 13, 2021

SELL
N/A
-150 Reduced 33.33%
300 $42,000
Q3 2016

Sep 13, 2021

BUY
N/A
10 Added 2.27%
450 $72,000
Q2 2016

Sep 07, 2021

BUY
N/A
40 Added 10.0%
440 $65,000
Q1 2016

Sep 07, 2021

BUY
N/A
400
400 $57,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $239B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Sargent Bickham Lagudis LLC Portfolio

Follow Sargent Bickham Lagudis LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.